Where Will Tricida Inc (TCDA) Stock Go Next After It Is Lower By 33.33% in a Week?

Monday, January 23, 2023 12:46 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Tricida Inc (TCDA) Stock Go Next After It Is Lower By 33.33% in a Week?

Overall market sentiment has been down on Tricida Inc (TCDA) stock lately. TCDA receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Tricida Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TCDA!

See Full TCDA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With TCDA Stock Today?

Tricida Inc (TCDA) stock is lower by -18.33% while the S&P 500 is up 1.28% as of 12:37 PM on Monday, Jan 23. TCDA has fallen -$0.02 from the previous closing price of $0.12 on volume of 19,809,937 shares. Over the past year the S&P 500 has fallen -8.77% while TCDA has fallen -98.94%. TCDA lost -$2.37 per share in the over the last 12 months. To screen for more stocks like Tricida Inc click here.

More About Tricida Inc

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis. Click Here to get the full Stock Report for Tricida Inc stock.